Characteristics | Group A (n = 304) (HMG300IU + MPA) | Group B (n = 274) (HMG300IU + MPA + CC) | P |
---|---|---|---|
Age (y) | 37.25 ± 5.10 | 36.93 ± 6.21 | 0.512 |
POSEIDON criteria | |||
Group 3, n (%) | 95 (31.25) | 107 (39.05) | 0.050 |
Group 4, n (%) | 209 (68.75) | 167 (60.95) | |
BMI (kg/m2) | 23.16 ± 2.85 | 23.57 ± 2.89 | 0.089 |
AMH (ng/mL) | 0.46 ± 0.29 | 0.42 ± 0.32 | 0.064 |
AFC | 2.95 ± 1.02 | 2.82 ± 1.03 | 0.085 |
Duration of infertility (y) | 4.09 ± 3.90 | 4.26 ± 4.12 | 0.129 |
Primary infertility, n (%) | 122 (40.13) | 124 (45.26) | 0.213 |
Cause of infertility, n (%) | |||
POR only | 34 (11.18) | 25 (9.12) | 0.414 |
POR + tubal | 174 (57.24) | 154 (56.20) | 0.802 |
POR + male | 78 (25.66) | 76 (27.74) | 0.572 |
POR + other | 18 (5.92) | 19 (6.93) | 0.619 |
ICSI rate, n (%) | 140 (46.05) | 122 (44.53) | 0.713 |